Publications by authors named "Hannah Chasseuil"
Photodistributed sarcoidosis with ophthalmic, arterial and pulmonary symptoms.
Photodermatol Photoimmunol Photomed
March 2020
Article Synopsis
- Nivolumab has a 40% response rate in metastatic melanoma, and the study aimed to identify blood biomarkers that predict survival for patients treated with it.
- Researchers evaluated 9 potential blood biomarkers from advanced melanoma patients over a 3-year period and used statistical analyses to find associations with overall and progression-free survival.
- Key findings indicated that higher levels of monocyte count, leukocyte/lymphocyte ratio, and neutrophil/lymphocyte ratio were linked to lower overall survival and progression-free survival, suggesting these markers could be helpful in forecasting patient responses to anti-PD1 therapy.